Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCelik, Serdar
dc.contributor.authorKizilay, Fuat
dc.contributor.authorYorukoglu, Kutsal
dc.contributor.authorAslan, Guven
dc.contributor.authorOzen, Haluk
dc.contributor.authorAkdogan, Bulent
dc.contributor.authorSozen, Sinan
dc.contributor.authorBaltaci, Sumer
dc.contributor.authorMuezzinoglu, Talha
dc.contributor.authorIzol, Volkan
dc.contributor.authorBayazit, Yildirim
dc.contributor.authorNarter, Fehmi
dc.contributor.authorTurkeri, Levent
dc.contributor.authorTurkish Urooncology Assoc
dc.date.accessioned2025-10-16T15:19:23Z
dc.date.issued2022
dc.identifier.doi10.1159/000513658
dc.identifier.otherWOS:000647856300001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7331
dc.publisherKARGER
dc.sourceUROLOGIA INTERNATIONALIS
dc.subjectProstate cancer
dc.subjectLow\\-risk and intermediate\\-risk prostate cancer
dc.subjectRadical prostatectomy
dc.subjectClinically insignificant prostate cancer
dc.subjectEpstein criteria
dc.subject12\\-core prostate biopsy scheme
dc.titleSextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS